AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 74 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 6.67 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $4,707,000 | +22.8% | 281,679 | +6.0% | 0.01% | 0.0% |
| Q1 2020 | $3,833,000 | -32.3% | 265,832 | +57.2% | 0.01% | -20.0% |
| Q4 2019 | $5,661,000 | -15.5% | 169,132 | -47.2% | 0.01% | +42.9% |
| Q3 2019 | $6,702,000 | +387.8% | 320,084 | +385.0% | 0.01% | +133.3% |
| Q2 2019 | $1,374,000 | -89.2% | 65,999 | -92.1% | 0.00% | -94.0% |
| Q2 2016 | $12,757,000 | +762.0% | 831,093 | +798.5% | 0.05% | +614.3% |
| Q1 2016 | $1,480,000 | -13.3% | 92,500 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $1,707,000 | -12.0% | 92,500 | +20.8% | 0.01% | -22.2% |
| Q3 2015 | $1,940,000 | – | 76,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 1,240,000 | $25,966,000 | 57.34% |
| Foresite Capital Management II, LLC | 2,605,499 | $54,559,000 | 11.53% |
| Foresite Capital Management III, LLC | 611,893 | $12,813,000 | 4.89% |
| Palo Alto Investors LP | 3,471,740 | $72,698,000 | 4.84% |
| SANDERS MORRIS HARRIS LLC | 486,906 | $10,196,000 | 2.47% |
| Eventide Asset Management | 3,084,000 | $64,579,000 | 2.13% |
| Sofinnova Investments, Inc. | 346,770 | $7,261,000 | 0.66% |
| EMERALD ADVISERS, LLC | 610,511 | $12,784,000 | 0.60% |
| RICE HALL JAMES & ASSOCIATES, LLC | 752,358 | $15,754,000 | 0.56% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 587,464 | $12,301,000 | 0.54% |